Article Text

Download PDFPDF
Systematic review with meta-analysis
Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs
  1. E Jennifer Edelman,
  2. Lynn E Fiellin
  1. Yale Medical Group, Yale School of Medicine, New Haven, Connecticut, USA
  1. Correspondence to : Lynn E Fiellin
    Yale Medical Group, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; lynn.sullivan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


Injection drug use (IDU), through the sharing of drug injection paraphernalia and concurrent sexual risk behaviours, continues to fuel the HIV epidemic.1 Approximately, 16 million individuals inject drugs globally, an estimated 3 million of whom are HIV infected, underscoring the need for effective intervention.1 Although opioid substitution therapy (OST) is an important component of HIV prevention,2 ,3 only 8 of 100 individuals globally with IDU receive OST.2 A recently completed systematic review by the Cochrane Collaborative concluded that OST leads to risk reduction and decreased HIV incidence.4 The review included …

View Full Text


  • Competing interests None.